What Aegis Ventures does

Aegis Ventures is a New York-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems (the Aegis Digital Consortium), representing over $100B in collective annual revenue. Founded in 2021 by Bill Schoenfeld (Chairman and CEO of APL Group, the founding investor and sponsor) and John Beadle (Managing Partner), the studio has launched six portfolio companies to date: Wavelet Medical (non-invasive AI-powered fetal EEG brain monitoring), Optain Health (AI retinal screening and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companion platform), Avandra (federated real-world medical imaging data network), and Ascertain (AI agent platform for healthcare workflow automation). The studio reports a 100% seed-to-Series A conversion rate across its portfolio, with $200M+ collectively raised by portfolio companies including a $26M Series A for Optain led by Insight Partners (September 2025) and a $7M seed for Wavelet (April 2026).

The studio's core technology is its venture studio model, which combines deep healthcare insights, aligned capital deployment, and proprietary customer access through the health system consortium to increase company creation velocity. Portfolio companies deploy proprietary AI across multiple modalities — computer vision (Optain retinal imaging, Wavelet fetal EEG signal processing), speech and audio (Hume EVI emotion analysis), autonomous agents (Caregentic, Ascertain), and structured data platforms (Avandra). The studio maintains an enterprise field sales go-to-market motion with no self-serve or consumer distribution; portfolio companies sell exclusively through direct enterprise contracts with health systems and healthcare organizations, often leveraging consortium relationships for clinical validation, early adoption, and deployment at scale.

Aegis's business model is venture studio equity ownership — the studio co-founds companies, provides operational expertise and capital, and realizes returns through portfolio company exits. Revenue is not publicly disclosed. The company is privately held, with APL Group (parent) as founding investor and Bill Schoenfeld as the largest shareholder. The leadership team includes David Feinberg, MD (Executive Chairman, former head of UCLA Health, Geisinger, Google Health, and current Oracle Health Chairman), John Noseworthy, MD (Chairman of the Digital Consortium and Venture Partner, former Mayo Clinic CEO), and multiple Venture Partners from Mayo Clinic, Apple Healthcare, McKinsey, and Walgreens Boots Alliance. The studio reports global portfolio company deployment across the U.S., South Korea, EU, UK, Australia, and New Zealand, and is recognized in Digital Health Insider's 2025 Top VCs in Healthcare ranking.

Name

Aegis Ventures

Legal name

Aegis Ventures

Website

https://aegisventures.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems. It has launched six portfolio companies spanning fetal monitoring, retinal screening, voice AI, patient engagement, imaging data, and workflow automation, reporting $200M+ in collective portfolio capital raised.

Ownership category

akta.pro rank

Product category

venture studio services

NAICS

Portfolio Management and Investment Advice (52394), Software Publishers (5132)

SIC

Investment Advice (6282), Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Venture Studios & Incubators (Build/launch ventures) (FSANAHAC)

akta.pro secondary industries

Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI), Corporate Strategic Partnership & Ecosystem Investment Arms (FSANAHAF), AI/ML Engineering & Model Development Services (BPAEAHAF)

Keywords

• Venture studio
• Healthtech investing
• AI healthcare startups
• Digital health consortium
• Portfolio company creation

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Venture Studio / Equity Ownership: Aegis Ventures generates returns through equity ownership in portfolio companies it co-founds and scales. The studio model combines capital, operational expertise, and health system partnerships to accelerate portfolio companies from seed through Series A, with 100% seed-to-Series A conversion rate cited. Returns are realized through portfolio company exits.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies. It combines deep healthcare insights, aligned capital, and proprietary customer access through a consortium of 14 leading health systems (the Aegis Digital Consortium) to co-create portfolio companies. The studio has launched six portfolio companies spanning disease detection, workflow automation, patient engagement, and real-world data, and reports a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies.

Product overview

Aegis Ventures is a NYC-based venture studio that builds AI-native healthtech companies. The company operates a portfolio of six distinct AI-powered healthcare products: Wavelet Medical (non-invasive fetal brain monitoring via EEG), Optain Health (AI retinal imaging and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companions), Avandra (real-world imaging data network), and Ascertain (workflow automation AI). These products collectively address disease detection, patient engagement, data monetization, and operational efficiency across healthcare settings.

Differentiator

Problem solved

Functional benefit

Brands

• Wavelet: AI-powered fetal brain monitoring platform enabling real-time detection of neurological distress in fetuses through non-invasive EEG technology.
• Ascertain
• Avandra
• Caregentic
• Hume
• Optain

Products and services

• Aegis Ventures Venture Studio NYC-based venture studio that combines deep healthcare insights, aligned capital, and proprietary access to customers through the 14-health-system Aegis Digital Consortium to build and scale AI-native healthtech companies. The studio reports having launched six portfolio companies and a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies collectively.
• Optain Health AI-backed retinal screening platform that combines AI, retinal imaging, and oculomics to enable non-invasive, rapid assessment of eye and cardiovascular conditions. Detects diabetic retinopathy, glaucoma, macular degeneration, and CVD with >90% accuracy across 10+ diseases in under 60 seconds, deployed across US, EU, UK, Australia, and New Zealand.
• Hume AI Emotionally intelligent voice AI platform that analyzes vocal emotional signals in real time and adapts tone to respond with expressive, lifelike speech. Empathic Voice Interface (EVI) and Octave text-to-speech engine power emotionally aware voice interactions for mental health, customer service, education, and conversational AI.
• Caregentic GenAI companion platform that serves as a 24/7 extension of care teams, deploying autonomous AI agents that execute complex clinical and administrative workflows including appointment scheduling, billing questions, care journey navigation, and clinical support via SMS, phone, and web, integrated with EHR systems.
• Avandra Real-world imaging data platform that enables compliant access to high-quality, standardized imaging (CT, MRI, PET, Ultrasound) from leading health systems to accelerate AI model development for pharma, biotech, and medical AI developers.
• Ascertain AI agents platform that automates healthcare workflows, transforms operations, and ushers in the workforce of the future for healthcare administration and prior authorization.

Quantifiable outcome

• 100% seed to Series A conversion across 5 portfolio companies launched
• +9 more outcomes

Named customers10 records

Segments1 record

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and key.

• Wavelet MedicalcoreStrategic or Co-development Partner · 14 April 2026Aegis Ventures entered a co-creation partnership with Wavelet Medical to commercialize a non-invasive, AI-powered fetal EEG monitoring platform developed at Yale. The partnership aims to scale the technology globally, with clinical trials underway at three U.S. sites. Wavelet Medical is a portfolio company spun out of Yale with $7M in seed funding.
• Bunny EllerinkeyOthers · 6 April 2026Bunny Ellerin appointed as Chief Ecosystem Officer at Aegis Ventures. She leads end-to-end founder and ecosystem development, sourcing top entrepreneurial talent, building the EIR and operator network, and driving strategic relationships across healthcare. Previously co-founded and led Digital Health New York (DHNY).
• Northwell HealthcoreStrategic or Co-development PartnerNorthwell Health is a core member of the Aegis Digital Consortium, collaborating to advance healthcare innovation by combining leading clinical, technology, and business resources. Northwell works with Aegis to fast-track creation of validated solutions that solve important challenges across the enterprise and can be replicated with health systems across the country.
• Memorial Hermann Health SystemcoreStrategic or Co-development PartnerMemorial Hermann views innovation as a disciplined pathway to solve real operational and clinical problems. The Aegis Digital Consortium provides a valuable forum for pragmatic insight-sharing and peer learning among health systems, helping shape scalable solutions to shared challenges.
• Indiana University HealthcoreStrategic or Co-development PartnerIndiana University Health participates in the Aegis Digital Consortium to partner with like-minded health systems in building and investing in new solutions at scale. Together they address common problems and create new businesses that will transform healthcare.
• Endeavor HealthcoreStrategic or Co-development PartnerEndeavor Health has a rigorous intake requirement which Aegis consistently meets. They are adopting, piloting, or co-developing with most of the portfolio companies and have swapped out incumbents for Aegis solutions.
• UPMC EnterprisescoreStrategic or Co-development PartnerUPMC Enterprises' partnership with the Digital Consortium enables building deep relationships with peer health system leaders, navigating healthcare challenges together, and collaborating to develop meaningful solutions and scale innovative companies.
• The Ohio State University Wexner Medical CentercoreStrategic or Co-development PartnerOSU Wexner's mission to drive innovative healthcare transformation aligns with the Aegis Digital Consortium. Through the consortium, they collaborate with other health systems to develop new solutions to help solve challenges facing the healthcare industry.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Redesign Health: Healthcare-focused venture studio that has launched 50+ healthcare companies. Directly comparable to Aegis in model (studio, not fund), vertical focus (healthcare), and company-creation approach, though Redesign has broader sector coverage and a larger capital base.
• Atomic: Venture studio that builds and funds companies from inception across multiple sectors. Directly comparable studio model to Aegis, though Atomic is more generalist in sector focus and lacks Aegis's healthcare-vertical depth and health system consortium.
• Founder Factory: Global venture studio that builds startups in partnership with corporates. Comparable studio model to Aegis with corporate-partner-led company creation; differs in sector focus (broader) and lacks Aegis's healthcare-specialized health system consortium.

Broad incumbents

• General Catalyst: Major venture firm with deep healthcare focus (Health Assurance thesis, committed $750M+ to healthcare) and a creation-oriented approach. Overlaps with Aegis in healthcare AI investment and in working closely with health systems, but operates primarily as a traditional fund rather than a studio.
• Andreessen Horowitz (a16z Bio/Health): Tier-1 venture firm with a dedicated Bio/Health fund. Competes with Aegis for healthcare AI founder relationships and portfolio investments; offers founders brand prestige and large check sizes that the studio model must counter with embedded customer access.
• Optum Ventures: Corporate venture arm of UnitedHealth Group focused on healthcare AI and digital health. Comparable in healthcare vertical and willingness to co-create with health system customers; competes for the same founder pool and AI-health deals.
• Khosla Ventures: Large venture firm with significant healthcare and AI exposure. Competes for healthcare AI deal flow and offers founders a different value proposition (broad sector network vs. Aegis's vertical healthcare studio model with health system consortium).
• Lux Capital: Science and technology-focused venture firm with healthcare AI portfolio (including AI-native healthtech companies). Comparable in backing technical founders in healthcare AI; differs from Aegis's venture-studio structure and health-system consortium model.

Emerging players

• SpringTide Ventures: Healthtech-focused venture firm investing in AI-enabled healthcare companies. Comparable healthcare-vertical focus and AI-native investment thesis; differs from Aegis in operating as a traditional fund rather than a venture studio.
• Flare Capital Partners: Healthcare-focused venture firm investing in early-stage healthtech and digital health companies. Comparable in healthcare vertical and early-stage focus; differs from Aegis's studio model with embedded health system consortium.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/aegisventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aegis Ventures